C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 14/435 (2006.01)
Patent
CA 2595935
The present invention relates to a chemotactically active epitope derivable from the urokinase receptor, a mutated peptide that acts as an inhibitor of chemotaxis, and their therapeutic use.
L'invention concerne un épitope chimiotactiquement actif, qui peut être dérivé du récepteur de l'urokinase, un peptide muté qui agit comme inhibiteur de la chimiotaxie, et l'utilisation thérapeutique de ceux-ci.
Blasi Francesco
Czekay Ralf-Peter
Degryse Bernard
Loskutoff David J.
Resnati Massimo
Fondazione Centro San Raffaele Del Monte Tabor
Sim & Mcburney
The Scripps Research Institute
LandOfFree
Therapeutic peptides derived from urokinase plasminogen... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic peptides derived from urokinase plasminogen..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic peptides derived from urokinase plasminogen... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1456083